DOI: 10.36347/sasjs.2021.v07i03.006

Pages: 134-136

We combined an adjuvant Everolimus therapy and a radical nephrectomy to treat a case of papillary renal cell carcinoma. The latter was revealed by a right limp linked to a pelvic metastasis in a 43-years-old female. Starting at the fifth post-nephrectomy month, the patient took 10 milligrams of Everolimus daily for 6 months. There was no significant regression of the pelvic (right acetabulum and iliopubic ramus), hepatic (segments IV and V) and spinal metastases (L2 and S1 vertebral bodies). The right acetabulum was fractured which apparently resulted more from the body weight than from a worsening of the metastatic lesion. However no new metastatic sites were noticed. The patient survived for ten months and one week. Everolimus adjuvant to radical nephrectomy had apparently stabilized the metastatic lesions but achieved a less-than-a-year survival in our patient.